SenoRx Announces Second Quarter 2008 Webcast and Conference Call
10. Juli 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., July 10, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host a conference call to review its second quarter 2008 financial results on Tuesday, August...
SenoRx Receives Additional 510(k) Clearance for Its Contura MLB
01. Juli 2008 09:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., July 1, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a second...
SenoRx Announces Court Grants Jointly Requested Stay of Proceedings
24. Juni 2008 11:18 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 24, 2008 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that the United States District Court for the Northern District of California has granted a joint request by...
SenoRx Appoints A. Thomas Bender to Board of Directors
06. Juni 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 6, 2008 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced the appointment of A. Thomas Bender to its board of directors, effective June 5, 2008. Mr. Bender is...
SenoRx to Present At Needham 7th Annual Biotechnology and Medical Technology Conference
02. Juni 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 2, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Needham 7th Annual...
SenoRx Announces Court Dismisses Unfair Competition and False Advertising Claims
27. Mai 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 27, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO), a company that manufactures and sells minimally invasive medical devices used by breast care specialists for the...
SenoRx Reports First Quarter 2008 Revenue Grows 38.7 Percent; Gross Margin Increases to 62.1 Percent From 54.1 Percent a Year Ago
12. Mai 2008 20:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 12, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2008. Revenue for the quarter increased 38.7...
SenoRx to Present at Two Investor Conferences in May
07. Mai 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 7, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following...
SenoRx Appoints John Buhler as Vice President of International Sales and Business Development
06. Mai 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 6, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced the appointment of John T. Buhler as Vice President of International Sales and Business Development....
SenoRx Receives Clearance for Modification to Its Contura MLB Product Warning Label
05. Mai 2008 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 5, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has received clearance to modify a warning on its Contura(tm) Multi-Lumen Radiation Balloon...